Company Filing History:
2 out of 13 
2 out of 6 
1 out of 832,812 Years Active: 2004-2009
Title: Exploring the Innovations of Inventor Frank Becker
Introduction
Frank Becker, an accomplished inventor based in Planegg, Germany, has made significant contributions to the field of biotechnology. He has been granted three patents, showcasing his innovative approach to addressing complex biological processes. His work primarily focuses on cell-cycle regulation and ligand binding, with potential applications in treating various disorders.
Latest Patents
Frank Becker's latest patents highlight his dedication to advancing medical science. One of his notable inventions is the development of novel cyclin-dependent kinase inhibitors (cdks). This invention addresses the challenge of inhibiting cdk/cyclin complexes, which play a crucial role in cell-cycle machinery. The inhibitors he has designed may be effective in modulating cell-cycle progression, offering potential treatments for disorders linked to excessive cell proliferation.
Another significant patent describes a hybrid assay system. This invention includes compositions and methods for isolating ligand binding polypeptides tailored to user-specified ligands. Additionally, it provides a technique for isolating small molecule ligands for specific target polypeptides—a valuable contribution to the field of drug discovery and development.
Career Highlights
Throughout his career, Frank Becker has collaborated with leading biotechnology companies. Notably, he has worked at GPC Biotech, Inc. and GPC Biotech AG, where he contributed to innovative projects and research initiatives. His experience in these companies has helped propel his inventions from concept to practical application.
Collaborations
Frank Becker’s work has involved collaboration with notable colleagues such as Jon H. Come and Nicholas Bockovich. These collaborations have further enriched his research and led to advancements in the understanding of cell-cycle dynamics and ligand interactions.
Conclusion
Frank Becker's journey as an inventor in Planegg, Germany, reflects his passion for innovation in biotechnology. With three patents to his name, his contributions, particularly in the development of cyclin-dependent kinase inhibitors and hybrid assay systems, hold promise for medical advancements. As he continues to work alongside talented professionals, the impact of his inventions is likely to expand, leading to new treatments and deeper insights into cellular processes.